| Price | 1.025p on 08-05-2026 at 14:30:16 |
|---|---|
| Change | 0.075p 7.89% |
| Buy | 1.05p |
| Sell | 1.00p |
| Last Trade: | Buy 94,476.00 at 1.05p |
| Day's Volume: | 47,220,143 |
| Last Close: | 0.95p |
| Open: | 0.95p |
| ISIN: | GB00B1VKB244 |
| Day's Range | 0.95p - 1.20p |
| 52wk Range: | 0.22p - 1.55p |
| Market Capitalisation: | £16.46m |
| VWAP: | 1.091895p |
| Shares in Issue: | 1.61b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Genedrive (GDR) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 94,476 | 1.05p | Ordinary |
15:30:14 - 08-May-26 |
| Buy* | 132,001 | 1.05p | Ordinary |
15:24:17 - 08-May-26 |
| Buy* | 715,865 | 1.04p | Ordinary |
14:58:40 - 08-May-26 |
| Buy* | 20,000 | 1.04p | Ordinary |
14:58:14 - 08-May-26 |
| Buy* | 25,000 | 1.04p | Ordinary |
14:52:01 - 08-May-26 |
| Buy* | 100,000 | 1.04p | Ordinary |
14:49:02 - 08-May-26 |
| Buy* | 47,693 | 1.04p | Ordinary |
14:45:26 - 08-May-26 |
| Sell* | 250,952 | 1.022p | Ordinary |
14:17:58 - 08-May-26 |
| Buy* | 57,581 | 1.042p | Ordinary |
14:16:25 - 08-May-26 |
| Sell* | 34,314 | 1.022p | Ordinary |
14:15:00 - 08-May-26 |
Genedrive (GDR) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 6th May 2026 11:56 am | RNS | Holding(s) in Company |
| 5th May 2026 7:00 am | RNS | Sussex NHS Trust transitions MT-RNR1 test to BAU |
| 21st Apr 2026 7:00 am | RNS | NHS England commercial strategy for MT-RNR1 |
| 20th Apr 2026 7:00 am | RNS-R | Interactive Investor Hub Updates |
| 16th Apr 2026 7:00 am | RNS | CYP2C19 kit implemented in North Bristol NHS Trust |
| 30th Mar 2026 7:00 am | RNS | Interim Results to 31 December 2025 |
| 12th Mar 2026 9:52 am | RNS | Holding(s) in Company |
| 12th Mar 2026 7:00 am | RNS | Holding(s) in Company |
| 12th Mar 2026 7:00 am | RNS | Holding(s) in Company |
| 11th Mar 2026 3:22 pm | RNS | Holding(s) in Company |
